Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Tumour-associated macrophages (TAMs) are enriched in glioblastoma multiformes (GBMs) that contain glioma stem cells (GSCs) at the apex of their cellular hierarchy. The correlation between TAM density and glioma grade suggests a supportive role for TAMs in tumour progression. Here we interrogated the molecular link between GSCs and TAM recruitment in GBMs and demonstrated that GSCs secrete periostin (POSTN) to recruit TAMs. TAM density correlates with POSTN levels in human GBMs. Silencing POSTN in GSCs markedly reduced TAM density, inhibited tumour growth, and increased survival of mice bearing GSC-derived xenografts. We found that TAMs in GBMs are not brain-resident microglia, but mainly monocyte-derived macrophages from peripheral blood. Disrupting POSTN specifically attenuated the tumour-supportive M2 type of TAMs in xenografts. POSTN recruits TAMs through the integrin αvβ₃ as blocking this signalling by an RGD peptide inhibited TAM recruitment. Our findings highlight the possibility of improving GBM treatment by targeting POSTN-mediated TAM recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Periostin (Postn) is shown to be required for alternative (less inflammatory) activation of microglia in brain tumors (Zhou et al., 2015).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Zhou et al., 2015
Experimental — accuracy not yet measuredIn the citing paper
“TD2 genes were well characterized for regulation of phagocytosis and microglial activation (e.g. Lgasl3; Rotshenker, 2009), microglial survival (e.g. Spp1; Rabenstein et al., 2016), alternative M2 activation of microglia (Zhou et al., 2015), and lysosomal proton pump (Atp6v0d2).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Zhou et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Crypt stem cells as the cells-of-origin of intestinal cancer
Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J., & Clevers, H. (2009) · Nature · doi:10.1038/nature07602 · Cited by 2,166
Research works printed but not linked: 1
- Cheng L Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth Cell 153 139 152 2013 23540695 PMC3638263
Cited by
Items 401–500 of 942
Huang, S., Zhao, Z., Weng, G., He, X., Wu, C., Fu, C., Sui, Z., Ma, Y., & Liu, T. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.008 · Cited by 34
Sánchez-Díaz, P. C., Chang, J. C., Moses, E. S., Dao, T., Chen, Y., & Hung, J. Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176879 · Cited by 38
Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic Viruses
Crupi, M. J. F., Bell, J. C., & Singaravelu, R. (2019) · Stem Cells · doi:10.1002/stem.3004 · Cited by 38
Cao, J., Guo, Q., Guan, G., Zhu, C., Zou, C., Zhang, L., Cheng, W., Wang, G., Cheng, P., Wu, A., et al. (2020) · Aging · doi:10.18632/aging.102706 · Cited by 36
“Human peripheral blood mononuclear cell (PBMC) were isolated by Ficoll-Paque PLUS (GE Healthcare) centrifugation media from health donor’s blood as previously described [38].”
BackgroundMethodPeriostin Is Expressed by Pericytes and Is Crucial for Angiogenesis in Glioma
Huizer, K., Zhu, C., Chirifi, I., Krist, B., Zorgman, D., van der Weiden, M., van den Bosch, T. P. P., Dumas, J., Cheng, C., Kros, J. M., et al. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa067 · Cited by 41
“Antibodies for periostin, CD31, PDGFRb, SOX2, and OLIG2 were used as previously described (2) (Table 2).”
BackgroundInfluentialContextual cues from cancer cells govern cancer-associated fibroblast heterogeneity
Bota‐Rabassedas, N., Banerjee, P., Niu, Y., Cao, W., Luo, J., Xi, Y., Tan, X., Sheng, K., Ahn, Y., Lee, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109009 · Cited by 34
Roccuzzo, G., Giordano, S., Fava, P., Pileri, A., Guglielmo, A., Tonella, L., Sanlorenzo, M., Ribero, S., Fierro, M. T., & Quaglino, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.733770 · Cited by 38
Molecular imaging of tumor-associated macrophages in cancer immunotherapy
Li, X., Wang, R., Zhang, Y., Han, S., Gan, Y., Liang, Q., Ma, X., Rong, P., Wang, W., & Li, W. (2022) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359221076194 · Cited by 42
Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements
Wang, Y., Zhu, N., Liu, J., Chen, F., Song, Y., Ma, Y., Yang, Z., & Wang, D. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06508-0 · Cited by 56
Immunopathology of Glioblastoma
Li, J., Ross, J., Hambardzumyan, D., & Brat, D. J. (2025) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-042524-025950 · Cited by 47
Hostile Takeover: Glioma Stem Cells Recruit TAMs to Support Tumor Progression
Shi, Y., Ping, Y., Zhang, X., & Bian, X. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.02.008 · Cited by 36
“A recent study by Bao’s group identified Periostin (POSTN) as one of the key cytokines preferentially secreted by GSCs (Zhou et al., 2015).”
BackgroundMethodResultInfluentialHarnessing Radiation Biology to Augment Immunotherapy for Glioblastoma
Rajani, K. R., Carlstrom, L. P., Parney, I. F., Johnson, A. J., Warrington, A. E., & Burns, T. C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00656 · Cited by 35
“For example, GSCs secrete periostin to recruit TAMs that largely exhibit an M2 phenotype (220).”
BackgroundXiao, F., Zhang, L., Ke, S., Liu, T., Hao, L., Zhao, P., Tu, W., & Cang, S. (2020) · Oncology Letters · doi:10.3892/ol.2020.11787 · Cited by 35
“GAM with the M2 phenotype has protumoral and immunosuppressive properties (58,59).”
Tatari, N., Khan, S., Livingstone, J. M., Zhai, K., McKenna, D., Ignatchenko, V., Chokshi, C., Gwynne, W. D., Singh, M. P., Revill, S. D., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02506-4 · Cited by 36
“In addition, Periostin (POSTN), previously described in the literature [52] as a tumor associated macrophage (TAM) marker of rGBM, was also enriched in the rGBM cohort, further validating the observation of upregulated immune-related proteins in rGBMs.”
ResultSilver, A., Feier, D., Ghosh, T., Rahman, M., Huang, J., Sarkisian, M. R., & Deleyrolle, L. P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1022716 · Cited by 42
Field, S., Uyttenhove, C., Stroobant, V., Chéou, P., Donckers, D., Coutelier, J., Simpson, P. T., Cummings, M. C., Saunus, J. M., Reid, L., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29946 · Cited by 35
“POSTN also has the potential to impair anti-tumour immune responses by attracting M2 monocytes/macrophages to the tumour niche as recently observed in experimental glioblastoma multiforme.(25) These data suggest that inhibiting the effects of POSTN could have a place in anti-tumour therapies.”
BackgroundToward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen
Salacz, M. E., Kast, R. E., Saki, N., Brüning, A., Karpel‐Massler, G., & Halatsch, M. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s100407 · Cited by 35
“One molecule that appears to be primarily secreted from the stem cell subpopulation of glioblastoma cells is periostin, which contributes to M2 differentiation.(27) Several other studies have demonstrated that malignant glioblastoma cells will also synthesize and secrete granulocyte–macrophage colony-stimulating facto…”
BackgroundGuo, X.-D., Ji, J., Xue, T.-F., Sun, Y., Guo, R., Cheng, H., & Sun, X. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00178 · Cited by 33
Fan, D., Yue, Q., Chen, J., Wang, C., Yu, R., Jin, Z., Yin, S., Wang, Q., Luo, C., Liao, X., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1932061 · Cited by 40
3D bioprinting technology to mimic the tumor microenvironment: tumor-on-a-chip concept
Samadian, H., Jafari, S., Sepand, M. R., Alaei, L., Malvajerd, S. S., Jaymand, M., Ghobadinezhad, F., Jahanshahi, F., Hamblin, M. R., Derakhshankhah, H., et al. (2021) · Materials Today Advances · doi:10.1016/j.mtadv.2021.100160 · Cited by 36
Li, W., Wang, X., Li, C., Chen, T., & Yang, Q. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.12.002 · Cited by 33
Therapy-induced shaping of the glioblastoma microenvironment: Macrophages at play
Erbani, J. M., Boon, M., & Akkari, L. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.05.003 · Cited by 37
The Evolution of Tumor Microenvironment in Gliomas and Its Implication for Target Therapy
Hu, Y., Li, Z., Zhang, Y., Wu, Y. C., Liu, Z., Zeng, J., Hao, Z., Li, J., Ren, J., & Yao, M. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.83531 · Cited by 37
“Some flow cytometry experiments have demonstrated that the majority of TAMs in gliomas are derived from monocyte-derived macrophages but not resident microglia [18].”
BackgroundPrakoura, N., & Chatziantoniou, C. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2650-6 · Cited by 32
“Periostin has been previously shown to mediate adhesion and migration of different cell types, such as cancer cells, vascular smooth muscle cells and macrophages, though interactions with cell-surface integrins [15, 43, 44].”
BackgroundKang, S., Ughetta, M. E., Zhang, J. Y., Marallano, V. J., Sattiraju, A., Hannah, T., Wahane, S., Ramakrishnan, A., Estill, M. S., Tsankova, N. M., et al. (2025) · Nature Cancer · doi:10.1038/s43018-025-00985-4 · Cited by 40
“TAMs are particularly abundant in GBM (constituting up to 50% of all cells in the tumor 3 ) with a supportive role for tumor expansion 4–6 .”
The impact of autophagy during the development and survival of glioblastoma
Simpson, J. E., & Gammoh, N. (2020) · Open Biology · doi:10.1098/rsob.200184 · Cited by 37
“These TAMs express an anti-inflammatory ‘M2’ phenotype, which is associated with tumour cell immune evasion [12,13].”
BackgroundAkinjiyan, F. A., Dave, R. M., Alpert, E., Longmore, G. D., & Fuh, K. C. (2022) · Cancers · doi:10.3390/cancers14143482 · Cited by 34
“Tumorderived POSTN is important for the recruitment of M2-like macrophages during tumor progression [53,54].”
BackgroundChen, B., Zhou, X., Yang, L., Zhou, H., Meng, M., Wu, H., Liu, Z., Zhang, L., & Li, C. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13956 · Cited by 31
Genetic Abnormalities, Clonal Evolution, and Cancer Stem Cells of Brain Tumors
Testa, U., Castelli, G., & Pelosi, E. (2018) · Medical Sciences · doi:10.3390/medsci6040085 · Cited by 44
“Tumor-associated macrophages (TAMs) also play an important role in tumor microenvironment [321].”
BackgroundLiver Matrix in Benign and Malignant Biliary Tract Disease
Fabris, L., Cadamuro, M., Cagnin, S., Strazzabosco, M., & Gores, G. J. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1705109 · Cited by 31
Chaudhary, R., Morris, R. J., & Steinson, E. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577633 · Cited by 33
Crosstalk between β-Catenin and CCL2 Drives Migration of Monocytes towards Glioblastoma Cells
Aretz, P., Maciaczyk, D., Yusuf, S., Sorg, R. V., Hänggi, D., Liu, H., Liu, H., Dakal, T. C., Sharma, A., Bethanabatla, R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094562 · Cited by 35
“GSCs were already associated with recruitment of tumor-supportive immune cells, such as TAMs and MDSCs, which derive from circulating monocytes [62,63,78,79].”
BackgroundWei, X., Guo, S., Liu, Q., Liu, L., Huo, F., Wu, Y., & Tian, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076353 · Cited by 32
“In fact, several recent studies have gradually reported the role of periostin in regulating macrophages in other diseases, such as glioblastoma [49,50], spinal cord injury [51], and ovarian cancer [52].”
BackgroundInfluence of Innate Immunity on Cancer Cell Stemness
Pastò, A., Consonni, F. M., & Sica, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093352 · Cited by 34
“In this scenario, periostin, a secreted extracellular matrix protein produced by glioma stem cells, was shown to attract M2 TAMs, hence promoting tumor growth [102].”
BackgroundZarodniuk, M., Steele, A., Lü, X., Li, J., & Datta, M. (2023) · npj Genomic Medicine · doi:10.1038/s41525-023-00381-w · Cited by 35
Qiu, J., Zhao, R., Ma, C., Wang, Q., Li, B., Qi, Y., Pan, Z., Zhao, S., Wang, S., Gao, Z., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae268 · Cited by 35
Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
DiGiacomo, J. W., & Gilkes, D. M. (2018) · Targeted Oncology · doi:10.1007/s11523-018-0555-4 · Cited by 31
“TAM recruitment is not limited to CCL2 signaling; however, as glioblastoma stem cells recruit monocyte-derived M2 TAMs from the peripheral blood through the secretion of the ECM protein periostin [56].”
BackgroundStructural characterizations of human periostin dimerization and cysteinylation
Liu, J., Zhang, J., Xu, F., Lin, Z., Li, Z., & Liu, H. (2018) · FEBS Letters · doi:10.1002/1873-3468.13091 · Cited by 31
Li, J., Hou, W., Yang, Y., Deng, Q., Fu, H. E., Yin, Y., Duan, K., Feng, B., Guo, T., & Weng, J. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112700 · Cited by 30
Giles, B., Nakhjavani, M., Wiesa, A., Knight, T., Shigdar, S. L., & Samarasinghe, R. M. (2023) · Cancers · doi:10.3390/cancers15174376 · Cited by 30
“Glioblastoma stem cell (GSC) interactions with TAMs induce the secretion of transforming growth factor-β (TGF-β)1, favouring the conversion to pro-tumourigenic M2 macrophages through the preferential secretion of periostin, a chemoattractant, whose silencing through gene knockdown inhibited tumour growth in GSC-derive…”
BackgroundChen, J., Mao, S., Li, H., Zheng, M., Yi, L., Lin, J., & Lin, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182183 · Cited by 30
Miyako, S., Koma, Y., Nakanishi, T., Tsukamoto, S., Yamanaka, K., Ishihara, N., Azumi, Y., Urakami, S., Shimizu, M., Kodama, T., et al. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.12.010 · Cited by 30
“62,63 Periostin also induces FAP, fi broblast activation protein; HGIEN, high-grade intraepithelial neoplasia; MDSCC, moderately differentiated squamous cell carcinoma; PDSCC, poorly differentiated squamous cell carcinoma; POSTN, periostin; a -SMA, a -smooth muscle actin; T1, tumor invades the…”
BackgroundWang, H., Yao, L., Chen, J., Li, Y., Su, Z., Liu, Y., Li, W., Xiong, Y., Gao, H., Zhang, X., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03175-9 · Cited by 35
“Silencing POSTN expression in GSCs reduced the recruitment of TAMs, inhibited tumor growth and increased the survival rate of mice transplanted with GSCs [22].”
BackgroundResultInfluentialPD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
Cantero-Cid, R., Casas-Martín, J., Hernández-Jiménez, E., Cubillos‐Zapata, C., Varela-Serrano, A., Ortiz, J. A., Casarrubios, M., Montalbán-Hernández, K. M., Villacañas-Gil, I., Guerra, L., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4853-0 · Cited by 31
Microglia and macrophages in human glioblastomas: A morphological and immunohistochemical study
Kvisten, M., Mikkelsen, V. E., Stensj�en, A., Solheim, O. S., van der Want, J. J. L., & TORP, S. H. (2019) · Molecular and Clinical Oncology · doi:10.3892/mco.2019.1856 · Cited by 39
“general, these two antibodies are regarded as pan-markers of TAMs (14, 15).”
BackgroundAbsent in melanoma 2 regulates tumor cell proliferation in glioblastoma multiforme
Chen, P.-S., Shrivastava, G., Balcom, E. F., McKenzie, B., Fernandes, J. P., Branton, W. G., Wheatley, B. M., Petruk, K. C., van Landeghem, F. K. H., & Power, C. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03230-y · Cited by 30
Phagocytic glioblastoma-associated microglia and macrophages populate invading pseudopalisades
Saavedra-López, E., Roig-Martínez, M., Cribaro, G. P., Casanova, P. V., Gallego, J. M., Pérez‐Vallés, A., & Barcia, C. (2019) · Brain Communications · doi:10.1093/braincomms/fcz043 · Cited by 30
“Tumour infiltrated macrophages/microglia play a supportive role of GBM (Zhou et al., 2015); thus, it is critical to understand their behaviour within the different microenvironments of the tumour and how interplay with the growth of the tumour mass occurs.”
BackgroundRoles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer
Liu, Q., Sun, W., & Zhang, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.875384 · Cited by 37
Liang, X., Wang, Z., Dai, Z., Zhang, H., Zhang, J., Luo, P., Liu, Z., Liu, Z., Yang, K., Cheng, Q., et al. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00569-9 · Cited by 37
“Glioblastoma-secreted periostin encoded by POSTN recruited M2 macrophages to promote cancer growth [56].”
BackgroundGan, C., Li, M., Lu, Y., Peng, G., Li, W., Wang, H., Peng, Y., Hu, Q., Wei, W., Wang, F., et al. (2023) · BMC Gastroenterology · doi:10.1186/s12876-022-02621-2 · Cited by 31
“Recent evidence revealed that POSTN could recruit M2 tumor-related macrophages and promote malignant growth [46].”
BackgroundChen, M., Zheng, S., Yang, M., Chen, Z., & Li, S. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-2776-x · Cited by 28
“Besides that, in glioma, it was reported that macrophages could be recruited and induced to become M2 phenotypes by a wide variety of factors secreted by tumor cells including IL-6, IL-10, TGF beta and periostin [36, 37].”
BackgroundNew Advances and Challenges of Targeting Cancer Stem Cells
Dashzeveg, N. K., Taftaf, R., Ramos, E. K., Torre-Healy, L. A., Chumakova, A. P., Silver, D. J., Alban, T. J., Sinyuk, M., Thiagarajan, P. S., Jarrar, A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0054 · Cited by 27
“GSCs recruit tumor-supportive TAMs (M2) by secreting periostin, which binds to avb3 integrin on TAMs (34).”
Zhang, Q., Zhang, J., Tian, Y., Zhu, G., Liu, S., & Liu, F. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00485-1 · Cited by 31
Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?
Gazaille, C., Sicot, M., Saulnier, P., Eyer, J., & Bastiat, G. (2021) · Frontiers in Medical Technology · doi:10.3389/fmedt.2021.791596 · Cited by 35
Cancer stem cells in brain tumors: From origin to clinical implications
Lin, S., Li, K., & Qi, L. (2023) · MedComm · doi:10.1002/mco2.341 · Cited by 30
Castellani, G., Buccarelli, M., D’Alessandris, Q. G., Ilari, R., Cappannini, A., Pedini, F., Boe, A., Lulli, V., Parolini, I., Giannetti, S., et al. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03253-0 · Cited by 28
“Moreover, silencing of POSTN in xenografts specifically attenuated the tumor-supportive M2 type of TAMs that promote tumor progression and counteract the antitumor effects of T lymphocytes [54].”
BackgroundZhang, Y., Yuan, D., Yao, Y., Sun, W., Shi, Y. P., & Su, X. (2017) · Tumor Biology · doi:10.1177/1010428317698367 · Cited by 30
Khalafallah, A. M., Huq, S., Jimenez, A. E., Serra, R., Bettegowda, C., & Mukherjee, D. R. (2020) · Neurosurgery · doi:10.1093/neuros/nyaa305 · Cited by 28
An update on the clinical trial research of immunotherapy for glioblastoma
Zhou, Y., Shi, F., Zhu, J., & Yuan, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1582296 · Cited by 40
“…resulting in reduction of tumor burden (148); Genetic silencing of POSTN in GSC-derived GBM models signi fi cantly prolonged overall survival (148); Both F4/80-targeted and folate receptor-directed CAR-T cells demonstrated signi fi cant tumor growth delay in ovarian cancer models (156, 157),…”
InfluentialCEP55 promoted the migration, invasion and neuroshpere formation of the glioma cell line U251
Li, F., Jin, D., Guan, L., Zhang, C., Wu, T., Wang, Y., & Gao, D. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.038 · Cited by 27
Molina, M. L., García‐Bernal, D., Salinas, M. D., Rubio, G., Aparicio, P., Moraleda, J. M., Martínez, S., & Valdor, R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.797945 · Cited by 27
“Periostin is a matrix protein that recruits pro-tumoral macrophages and enhances GB progression in mice (Zhou et al., 2015), and recently, it has been reported to be expressed by PC in gliomas, favoring angiogenesis (Huizer et al., 2020).”
Connolly, N. P., Shetty, A. C., Stokum, J. A., Hoeschele, I., Siegel, M. B., Miller, C. R., Kim, A. J., Ho, C., Dávila, E., Simard, J. M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19451-6 · Cited by 28
Living Cells and Cell-Derived Vesicles: A Trojan Horse Technique for Brain Delivery
Ou, A., Wang, Y., Zhang, J., & Huang, Y. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041257 · Cited by 26
“Circulating monocytes serve as a primary source of tumor-associated macrophages (TAMs) in glioblastoma [41,44], and thus represent a promising cell carrier candidate for brain tumor-targeted delivery.”
BackgroundXu, F., Li, S., Zhang, J., Wang, L., Wu, X., Wang, J., Huang, Q., & Lai, M. (2018) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2018.05.007 · Cited by 28
Phenotypic plasticity of myeloid cells in glioblastoma development, progression, and therapeutics
Ye, Z., Ai, X., Zhao, L., Fei, F., Wang, P., & Zhou, S. (2021) · Oncogene · doi:10.1038/s41388-021-02010-1 · Cited by 30
“Blocking POSTN inhibited the recruitment of tumor-supportive TAMs into GBM tissues and improved GBM treatment efficacy [27].”
BackgroundInfluentialWang, Y., Gong, X., Li, J., Wang, H., Xu, X., Wu, Y., Wang, J., Wang, S., Li, Y., & Zhang, Z. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01143-5 · Cited by 28
The neuropathological basis to the functional role of microglia/macrophages in gliomas
Schiffer, D., Mellai, M., Bovio, E., & Annovazzi, L. (2017) · Neurological Sciences · doi:10.1007/s10072-017-3002-x · Cited by 26
Aberrant expression of RSK1 characterizes high‐grade gliomas with immune infiltration
Hajj, G. N. M., da Silva, F. F., de Bellis, B., Lupinacci, F. C. S., Bellato, H. M., Cruz, J. R., Segundo, C. N. C., Faquini, I. V., Torres, L. C., Sanematsu, P., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12595 · Cited by 24
“Gliomas are tumors of the central nervous system resulting from the malignant transformation of glial cells, their intermediate precursors, and neural stem cells (Huse and Holland, 2010; Zong et al., 2015).”
BackgroundWang, X., Jian, Q., Zhang, Z., Gu, J., Wang, X., & Wang, Y. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102076 · Cited by 33
“In addition, POSTN secreted by glioblastoma stem cells stimulates malignant growth by recruiting M2 tumor-associated macrophages [46].”
BackgroundGlioma Cell Secretion: A Driver of Tumor Progression and a Potential Therapeutic Target
Bonnin, D. A. A., Havrda, M. C., & Israel, M. A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0345 · Cited by 25
Prognostic significance of periostin in colorectal cancer
Deng, X., Ao, S., Hou, J., Li, Z., Lei, Y., & Lyu, G. (2019) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2019.03.16 · Cited by 26
Periostin deficiency attenuates lipopolysaccharide‐ and obesity‐induced adipose tissue fibrosis
Yang, Y., Zhang, Y., Zhou, X., Chen, D., Ouyang, G., Liu, Y., & Cui, D. (2021) · FEBS Letters · doi:10.1002/1873-3468.14154 · Cited by 24
Han, X., Wang, Q., Fang, S., Wang, J., Liu, F., Zhang, J., & Jin, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.836511 · Cited by 24
“GSCs are localized to and maintained in the glioma niche and are involved in glioblastoma vascularization and resistance to treatment (21, 39, 40).”
BackgroundPericyte–Glioblastoma Cell Interaction: A Key Target to Prevent Glioblastoma Progression
Pombero, A., García‐López, R., & Martínez, S. (2023) · Cells · doi:10.3390/cells12091324 · Cited by 25
Kudō, A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-6657-4_2 · Cited by 24
Tumor Niches: Perspectives for Targeted Therapies in Glioblastoma
Srivastava, R., Dodda, M., Zou, H., Li, X., & Hu, B. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0187 · Cited by 24
Xiong, J., Zhou, X., Su, L., Jiang, L., Ming, Z., Pang, C., Fuller, C., Xu, K., Chi, H., & Zheng, X. (2024) · Discover Oncology · doi:10.1007/s12672-024-01464-5 · Cited by 24
“This is in contrast to classical T cell suppression [91].”
ResultNSE from diffuse large B-cell lymphoma cells regulates macrophage polarization
Zhu, M.-Y., Liu, W.-J., Wang, H., Wang, W.-D., Liu, N.-W., & Lu, Y. (2019) · Cancer Management and Research · doi:10.2147/cmar.s203010 · Cited by 23
“Exosomes act as mediators by transferring proteins and genetic contents between tumor and stromal cells.(27,28) In cancer cells, exosomes play important roles in intercellular communication and promote the M2like functional polarization of TAMs.”
BackgroundFeng, R., Tian, K., Zhang, Y., Liu, W., Fang, J., Khan, M. S., Wei, Q. L., & Wu, R. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112367 · Cited by 23
Ma, Y., He, L., Zhao, X., Li, W., Lv, X., Zhang, X., Peng, J., Yang, L., Xu, Q., & Wang, H. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.08.032 · Cited by 28
Liu, X., Liu, Y., Qi, Y., Huang, Y., Hu, F., Dong, F., Shu, K., & Lei, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.822085 · Cited by 31
“GDNF Chemokine (58) POSTN GSCs secreted POSTN to recruit TAMs through the integrin avb3 (59)”
BackgroundHorst, E. N., Bregenzer, M. E., Mehta, P., Snyder, C. S., Repetto, T., Yang‐Hartwich, Y., & Mehta, G. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.04.041 · Cited by 27
Zhu, C., Chen, X., Liu, T., Cheng, L. L., Cheng, W., Cheng, P., & Wu, A. (2024) · Nature Communications · doi:10.1038/s41467-024-52888-0 · Cited by 32
Cancer stem cells and tumor-associated macrophages: Interactions and therapeutic opportunities
Yuan, H., Qiu, Y., Mei, Z., Liu, J., Wang, L., Zhang, K., Liu, H., & Zhu, F. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217737 · Cited by 24
Liebelt, B. D., Finocchiaro, G., & Heimberger, A. B. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802997-8.00010-4 · Cited by 24
Hiraiwa, M., Fukasawa, K., Iezaki, T., Sabit, H., Horie, T., Tokumura, K., Iwahashi, S., Murata, M., Kobayashi, M., Suzuki, A., et al. (2022) · Communications Biology · doi:10.1038/s42003-021-02950-0 · Cited by 27
Majc, B., Habič, A., Novak, M., Rotter, A., Porčnik, A., Mlakar, J., Župunski, V., Fonović, U. P., Knez, D., Zidar, N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031784 · Cited by 32
“As macrophages are found in perivascular GSC niches in GBM [19,21], this may explain the perivascular expression of cathepsin X in our previous study [34].”
BackgroundResultAramini, B., Masciale, V., Samarelli, A. V., Dubini, A., Gaudio, M., Stella, F., Morandi, U., Dominici, M., Biasi, S. D., Gibellini, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.959114 · Cited by 26
Martins, C., Pacheco, C., Moreira-Barbosa, C., Marques-Magalhães, Â., Dias, S., Araújo, M., Oliveira, M. J., & Sarmento, B. F. C. C. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.024 · Cited by 23
Ah-Pine, F., Septembre‐Malaterre, A., Bedoui, Y., Khettab, M., Neal, J., Freppel, S., & Gasque, P. (2023) · Cancers · doi:10.3390/cancers15092647 · Cited by 23
“These factors have been extensively studied and include CC-chemokine CCL2/MCP1, CCL7, glial cell line-derived neurotrophic factor (GDNF), VEGF, ATP (released from necrotic cells), macrophage colony-stimulating factor 1 (CSF1), granulocyte– macrophage colony-stimulating factor (GM–CSF) and periostin [27,50].”
BackgroundLi, S., Chen, Y., Xie, Y., Zhan, H., Zeng, Y., Zeng, K., Wang, L., Zhan, Z., Li, C., Zhao, L., et al. (2023) · Advanced Science · doi:10.1002/advs.202303561 · Cited by 24
Wang, T.-T., Yuan, J., Ma, J., Yang, W., Liu, X., Yin, Y., Liu, Y., Pan, W., & Sun, S. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.004 · Cited by 25
Metabolic Plasticity of Cancer Stem Cells in Response to Microenvironmental Cues
Xie, Y., Ma, S., & Tong, M. (2022) · Cancers · doi:10.3390/cancers14215345 · Cited by 23
Huang, S., Zhang, P., Yin, N., Xu, Z., Liu, X., Wu, A., Zhang, X., Li, Z., Zhang, Z., Zhong, T., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109270 · Cited by 26
“13 TAMs can secrete certain pro-angiogenic cytokines, growth factors, and angiogenic regulatory enzymes to trigger angiogenic switch for construction of glioblastoma vasculature, thus promoting tumor development.”
BackgroundMathan, S. V., & Singh, R. P. (2025) · Cancers · doi:10.3390/cancers17132100 · Cited by 25
“Periostin expressed on CSC membranes helps attract monocytes from the bloodstream and converts them into TAMs, supporting the survival of CSCs in the TME [42].”
Zeng, H., Li, H., Zhao, Y., Chen, L., & Ma, X. (2019) · Head & Neck · doi:10.1002/hed.25952 · Cited by 24
“Besides, POSTN was reported as progression-associated factor and poor prognostic biomarker in glioma through regulating the maintenance of cancer stem cell during disease progression.(39) In our study, we reached a similar conclusion that POSTN gene was significantly positively correlated with disease status and poor…”
BackgroundResultThe Eclectic Nature of Glioma-Infiltrating Macrophages and Microglia
Arrieta, V. A., Najem, H., Petrosyan, E., Lee-Chang, C., Chen, P., Sonabend, A. M., & Heimberger, A. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413382 · Cited by 23
“Particularly, survi al, maintenance, and pheno ype education of MDMs towards a tumor-supportive phenotype are mediated by t secretion of gl ma-derived facto s, incl ding CSF-1, p riostin, and NO [44,57,58].”
BackgroundHuang, S., Liu, L., Xu, Z., Liu, X., Wu, A., Zhang, X., Li, Z., Li, S., Li, Y., Yuan, J., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14296 · Cited by 21
“9 Moreover, M2 polarization of TAMs and tissue remodeling of GSCs have been reported to be increased in recurrent GBMs after treatment.”
BackgroundNeuroinflammation in Glioblastoma: The Role of the Microenvironment in Tumour Progression
Nóbrega, A. H. L., Pimentel, R. S., do Prado, A. P. S., Garcia, J., Frozza, R. L., & Bernardi, A. (2024) · Current Cancer Drug Targets · doi:10.2174/0115680096265849231031101449 · Cited by 26
Identification of COX5B as a novel biomarker in high-grade glioma patients
Hu, T., & Xi, J. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s139243 · Cited by 22
“23,26,27 In this study, we used bioinformatics to detail the global program of gene expression in different-grade glioma tissues and to try to identify some genes associated with the tumorigenesis of gliomas.”
Metadata
- Authors
- Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., Rich, J. N., & Bao, S.
- Affiliations
- Cleveland Clinic (US)
- University Hospitals Cleveland Medical Center (US)
- Duke Medical Center (US)
- Corresponding author
- Bao, Shideng
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2015-01-12
- Volume
- 17
- Issue
- 2
- Pages
- 170-182
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC4312504
- OpenAlex
- W2073586533
- Cited by
- 940
- References
- 67
- Citations by year
- 2026: 29 · 2025: 74 · 2024: 93 · 2023: 101 · 2022: 118 · 2021: 117 · 2020: 93 · 2019: 82 · 2018: 71 · 2017: 81 · 2016: 50 · 2015: 30
- FWCI
- 38.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cleveland Clinic
- National Institutes of Health (1r01ns071996-01a1)
- National Institute of General Medical Sciences (T32GM007250)
- National Institute of Allergy and Infectious Diseases (T32AI089474)
- National Institute of Neurological Disorders and Stroke (R01-NS071996, R01NS070315)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- periostin, glioblastoma, glioma stem cells, tumour-associated macrophages, M2 macrophages, macrophage recruitment, integrin αvβ3, RGD peptide, monocyte-derived macrophages, tumor microenvironment, tumor growth, therapeutic target
- MeSH terms
- Animals, Brain Neoplasms, Cell Count, Chemotactic Factors, Female, Fluorescent Antibody Technique, Glioblastoma, Humans, Luminescent Measurements, Macrophages, Mice, Inbred C57BL, Monocytes, Neoplastic Stem Cells, Signal Transduction, Cell Adhesion Molecules, Survival Analysis, Gene Silencing, Xenograft Model Antitumor Assays, RNA, Small Interfering, Integrin alphaVbeta3, Cell Line, Tumor, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.